Key Takeaways
- Zeiss and Envision Health Technologies have entered a strategic collaboration focused on advancing VR-based visual function testing for glaucoma care
- The partnership combines Zeiss' expertise in perimetry with Envision's software-driven and virtual reality technologies to strengthen the clinical credibility of VR perimetry
Zeiss announced a strategic collaboration with Envision Health Technologies aimed at advancing glaucoma care through gamified virtual reality (VR) technology and software-driven visual function testing.
Financial terms of the deal were not disclosed.
The collaboration aims to bring together Zeiss' expertise in perimetry and visual field testing with Envision Health Technologies' focus on digital eye health and VR-based diagnostic solutions. The companies said the initiative is intended to strengthen the scientific and clinical foundation of VR-based visual function assessment while supporting broader access to glaucoma screening and monitoring.
“As glaucoma care continues to evolve, clinicians are looking for solutions that improve patient accessibility, flexibility and experience without compromising clinical confidence,” said Anuj Kalra, head of chronic disease management at Zeiss Medical Technology. “Our collaboration with Envision Health Technologies reflects Zeiss’ commitment to advancing practical, clinician-driven innovation that can help expand access to visual function testing across a range of care settings.”
Envision Health Technologies was founded by glaucoma surgeon Lama A. Al-Aswad, MD, MPH, to develop data-driven technologies designed to improve outcomes for patients with vision-threatening diseases. The company has focused on creating software-based tools intended to transform how vision care is delivered, measured, and scaled.
“We believe the future of visual function testing should be more accessible, flexible, and patient-centered while remaining grounded in clinical rigor,” said Dr. Al-Aswad, who also serves as CEO of Envision Health. “Collaborating with Zeiss allows us to combine cutting-edge software innovation with decades of trusted market leadership in perimetry to help advance more practical solutions for real-world glaucoma care.”
According to the companies, the strategic collaboration will focus on helping shape the future direction of VR perimetry by integrating clinical expertise with emerging digital technologies. The effort is expected to support the development of clinically relevant testing solutions that maintain diagnostic confidence while improving patient experience and accessibility.
